an increasing trendP < 0.05
The expression of α-SMA, a marker of HSC activation, showed an increasing trend in the model group, which was reversed by HF-MSC treatment ( P < 0.05) ( Fig. 6 ).
The expression of α-SMA, a marker of HSC activation, showed an increasing trend in the model group, which was reversed by HF-MSC treatment ( P < 0.05) ( Fig. 6 ).
In addition, in contrast to that in the LC group, the α-SMA expression showed a decreasing trend in the treatment group in vitro and in vivo , indicating that the pathological activation of hepatic stellate cells (HSCs) was inhibited by HF-MSC treatment.